| Newsroom
The Media section provides reporters with easy access to Genentech information for stories in development. It also houses our recent and archived press releases. Recent Press Releases
Nov 18, 2009 Genentech and Biogen Idec Receive a Complete Response from the FDA for Rituxan for Chronic Lymphocytic Leukemia Nov 16, 2009 Genentech Submits Supplemental Applications to FDA for Avastin Combined with Commonly Used Chemotherapies for Women with Advanced Breast Cancer Oct 17, 2009 Phase III Study Showed Two Years of ACTEMRA ® (tocilizumab) Inhibited Progression of Joint Damage and Improved Disease Remission Oct 17, 2009 Genentech and Biogen Idec Receive a Complete Response from FDA for Earlier Use of Rituxan for Rheumatoid Arthritis  |
FOLLOW GENENTECH ON TWITTER
|
Media
|
|
